L. Stewart Massad Jr.

Medicine & Life Sciences

1. Uterine Cervical Neoplasms 100%
2. HIV 91%
3. Colposcopy 83%
4. Cell Biology 50%
5. Cervical Intraepithelial Neoplasia 46%
6. Papanicolaou Test 46%
7. Squamous Intraepithelial Lesions 37%
8. Early Detection of Cancer 34%
9. Neoplasms 24%
10. Papillomavirus Infections 20%
11. Guidelines 19%
12. Atypical Squamous Cells of the Cervix 18%
13. Biopsy 18%
14. Endometrial Neoplasms 16%
15. Human papillomavirus 16 15%
16. Confidence Intervals 14%
17. Survival 14%
18. Hysterectomy 13%
19. Natural History 13%
20. CD4 Lymphocyte Count 13%
21. HIV Infections 12%
22. Ovarian Neoplasms 12%
23. Incidence 12%
24. Pathology 11%
25. Uterine Cervical Dysplasia 10%
26. Radiotherapy 10%
27. Referral and Consultation 9%
28. Poverty 9%
29. HIV-1 9%
30. Odds Ratio 9%
31. Adenocarcinoma in Situ 9%
32. Therapeutics 8%
33. Highly Active Antiretroviral Therapy 8%
34. Oncologists 8%
35. Carcinoma 8%
36. Curettage 7%
37. Recurrence 7%
38. Human papillomavirus 18 7%
39. Triage 7%
40. Radiation 7%
41. Histology 7%
42. Interferons 7%
43. Drug Therapy 7%
44. Contraceptive Agents 6%
45. Platinum 6%
46. Therapeutic Irrigation 6%
47. Condylomata Acuminata 6%
48. Cervix Uteri 6%
49. Genitalia 6%
50. Vaccination 6%